Yescarta 200000000 Cells (Axicabtagene Ciloleucel SUSPENSION) 200000000 CELLS

YESCARTA 200000000 CELLS is a specialized suspension used in targeted therapy. This product, manufactured by Gilead Sciences Canada Inc., is designed for intravenous administration.

Strength

200000000 CELLS

Manufacturer / TM Owner

GILEAD SCIENCES CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

YESCARTA 200000000 CELLS is a type of cell-based therapy used in the treatment of certain types of cancer. It works by harnessing the body's immune system to target and destroy cancer cells. This therapy is often considered when other treatments have not been effective. The primary use of YESCARTA is in the management of specific cancers, providing a tailored approach to treatment.

Side Effects

YESCARTA 200000000 CELLS may cause various effects as the body adjusts to the therapy. Common effects can include fever, fatigue, and changes in blood pressure. These effects are typically monitored and managed by healthcare professionals to ensure patient safety and comfort.

Precautions & Warnings

Handling YESCARTA 20000000 CELLS requires careful attention to storage and administration guidelines. It should be stored and prepared under specific conditions to maintain its efficacy. Patients should be closely monitored for any adverse reactions, and healthcare providers should be informed of any pre-existing conditions or medications that may interact with the therapy.

Avoid Interactions

YESCARTA 20000000 CELLS may interact with other medications or therapies, particularly those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also impact the effectiveness and safety of this therapy.

Frequently Asked Questions

YESCARTA 200000000 CELLS is used in the treatment of certain types of cancer by utilizing the body's immune system to target cancer cells.

YESCARTA 200000000 CELLS is administered intravenously by healthcare professionals in a controlled medical setting.

Common effects may include fever, fatigue, and changes in blood pressure, which are typically monitored and managed by healthcare providers.

YESCARTA 200000000 CELLS requires careful handling and storage. Patients should be monitored for adverse reactions and inform healthcare providers of any pre-existing conditions or medications.

YESCARTA 200000000 CELLS may interact with medications that affect the immune system. It is important to discuss all current medications with a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.